6515--Monopolar Dual-Frequency Ophthalmic System for Dry Eyes

The Department of Veterans Affairs Coatesville VA Medical Center is conducting market research to identify qualified manufacturers that can supply a new FDA‑cleared Monopolar Dual‑Frequency RF ophthalmic system. The device must treat dry eye syndrome, meibomian gland disease, blepharitis, acne rosacea, and related periorbital skin conditions across all skin tones, using monopolar technology to prevent arcing and dual‑frequency RF to avoid pigment‑dependent effects and allow depth‑specific heating. Required capabilities include multiple RF frequencies, adjustable intensity, and compliance with the salient characteristics outlined in the Draft Statement of Need (e.g., FDA clearance for ophthalmic/optometric use, non‑pigment‑dependent operation). Vendors must demonstrate ability to meet these specifications, provide part numbers, and confirm compliance with FAR 52.225‑3 (Buy American‑Free Trade Agreements/Israeli Trade Act). Large businesses should also list any designated distributors and size status. Responses, limited to technical capability information (no generic marketing), must be emailed to Jeff Mann (jefferson.mann@va.gov) by 4:00 p.m. ET on 15 May 2026; the VA will not reimburse any response costs.

Notice ID

0e496108e92a4f7d8c8de86269d5ab23

Solicitation Number

36C24426Q0532

NAICS Code

339112

Classification Code

6515